RNA Clinical Trials Resources

  1. The Cell & Gene Therapy Clinical Trials Global Landscape 5/9/2023

    Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.

  2. What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan? 5/9/2023

    Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.

  3. Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific 5/9/2023

    Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.

  4. Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  5. Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  6. Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.

  7. Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.

  8. Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/8/2023

    Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  9. Expert Consulting, MRCT Strategy Rescues Oncology Program 5/8/2023

    Uncover how teams identified missing IB data and necessary additional details needed to outline U.S. study challenges as required for local authority approval in a previously failing study.

  10. Modulate mRNA Therapy Effectiveness Using Modified Ribonucleotides 3/20/2023

    Learn about the problem of immunogenicity of mRNA, modified mRNA via in vitro transcription production, and choosing fit-for-purpose modified ribonucleotides.